Variation in hospital utilization of palliative interventions for patients with advanced gastrointestinal cancer near end of life
Journal of Surgical Oncology · 2023-03 · 127 (4) · 741-751
DOI: 10.1002/jso.27177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 13.12.2022. Verfasst von Vivi W Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Innovations in Quality, Effectiveness, and Safety, Michael E DeBakey VA Medical Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Palliative Care, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Office of Research and Development.
Themen: Palliativpflege
Abstract (Originalsprache)
Background
Patients with advanced gastrointestinal (GI) cancer often undergo noncurative interventions with palliative intent to relieve high symptom burden near end of life. Hospital‐level variation in intervention utilization remains unclear.
Methods
National cohort study of 142 304 patients with stage III or IV GI cancer within the National Cancer Database (2004–2014) who died within 1‐year of diagnosis. Hospitals were stratified by palliative intervention utilization (surgery, chemotherapy, radiation, pain management). Multivariable, multinomial regression evaluated the association between patient/hospital factors and palliative intervention utilization.
Results
Across 1322 hospitals, median hospital palliative intervention utilization was 12.0% [interquartile range: 0.0%–26.1%]. Utilization increased over time in all but lowest utilizing hospitals. Relative to lowest utilizing hospitals, factors associated with a lower likelihood of care at highest utilizing hospitals included: race (White [ref]; Black—Relative Risk Ratio [RRR] 0.81, 95% confidence interval [0.77–0.85]) and lower income (RRR 0.81 [0.78–0.84]). Factors associated with a higher likelihood included: lower education level (RRR 1.62 [1.55–1.69]) and hospital type (community program [ref]; comprehensive community—RRR 1.33 [1.26–1.41]; academic—RRR 1.88 [1.77–1.99]; integrated network—RRR 1.79 [1.66–1.93]).
Conclusion
Hospital variation in palliative intervention use is substantial and potentially associated with sociodemographic and hospital characteristics. Future work can examine how differences in hospital care processes translate to quantity/quality of life for cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Innovations in Quality, Effectiveness, and Safety, Michael E DeBakey VA Medical Center, Houston, Texas, USA.
- Michael E DeBakey Department of Surgery at Baylor College of Medicine, Houston, Texas, USA.
- Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Surgical and Perioperative Care, Atlanta VA Health Care System, Decatur, Georgia, USA.
- Department of Surgery, Division of Surgical Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.
Förderung
- Office of Research and Development
Zitieren
APA
Chen, V. W., Portuondo, J. I., Cooper, Z., & Massarweh, N. N. (2023). Variation in hospital utilization of palliative interventions for patients with advanced gastrointestinal cancer near end of life. Journal of Surgical Oncology, 127(4), 741-751. https://doi.org/10.1002/jso.27177
Vancouver
Chen VW, Portuondo JI, Cooper Z, Massarweh NN. Variation in hospital utilization of palliative interventions for patients with advanced gastrointestinal cancer near end of life. Journal of Surgical Oncology. 2023;127(4):741-751. doi:10.1002/jso.27177
BibTeX
@article{Chen2023,
author = {Chen, Vivi W and Portuondo, Jorge I and Cooper, Zara and Massarweh, Nader N},
title = {Variation in hospital utilization of palliative interventions for patients with advanced gastrointestinal cancer near end of life},
journal = {Journal of Surgical Oncology},
year = {2023},
volume = {127},
number = {4},
pages = {741--751},
doi = {10.1002/jso.27177}
}
EUVIMED